Company profile
InBrain Pharma
- Industry
- Biotechnology Research
- Employees
- 5
- Headquarters
- Loos, Hauts-de-France
- Founded
- 2018
- LinkedIn followers
- 2,252
- Office locations
- 1
InBrain Pharma company summary
InBrain Pharma is a company in the Biotechnology Research industry, headquartered in Loos, Hauts-de-France, founded in 2018. On LinkedIn the company has around 5 employees and 2,252 followers.
What technology does InBrain Pharma use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About InBrain Pharma
InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results have just been obtained.
Where is InBrain Pharma located?
InBrain Pharma lists 1 location.
Compare companies similar to InBrain Pharma
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
InBrain Pharma inbrainpharma.com | Biotechnology Research | 5 | 2018 | Loos, Hauts-de-France |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about InBrain Pharma
What does InBrain Pharma do?
InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results have just been obtained.
How many employees does InBrain Pharma have?
InBrain Pharma has around 5 employees on LinkedIn.
Where is InBrain Pharma headquartered?
InBrain Pharma is headquartered in Loos, Hauts-de-France.
When was InBrain Pharma founded?
InBrain Pharma was founded in 2018.
Build a lead list from companies like InBrain Pharma
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.